INSULIN GLULISINE

INSULIN GLULISINE was reported 10207 times

INSULIN GLULISINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE LENTIGINES SYNDROME 13 0.3421
1 MEDICAL DEVICE SITE CELLULITIS 12 0.2069
2 DIABETIC BULLOSIS 6 0.1364
3 MEDICAL DEVICE SITE ABSCESS 7 0.1014
4 ANTI-INSULIN ANTIBODY POSITIVE 20 0.0957
5 ANTI-INSULIN ANTIBODY INCREASED 8 0.0860
6 PRODUCT GEL FORMATION 8 0.0656
7 HYPERINSULINAEMIC HYPOGLYCAEMIA 9 0.0405
8 HYDROCHOLECYSTIS 7 0.0378
9 SHOCK HYPOGLYCAEMIC 18 0.0378
10 MORGANELLA INFECTION 11 0.0375
11 BRONCHIAL HAEMORRHAGE 11 0.0353
12 DIABETIC METABOLIC DECOMPENSATION 43 0.0310
13 DIABETIC RETINAL OEDEMA 15 0.0295
14 BLOOD INSULIN ABNORMAL 5 0.0266
15 ATRIAL ENLARGEMENT 7 0.0257
16 HYPOGLYCAEMIC UNCONSCIOUSNESS 51 0.0257
17 CATARACT SUBCAPSULAR 15 0.0246
18 HAEMORRHAGIC EROSIVE GASTRITIS 8 0.0245
19 SUBSTANCE USE 34 0.0218
20 EPISCLERITIS 15 0.0217
21 ANAEMIA OF MALIGNANT DISEASE 6 0.0214
22 HYPOGLYCAEMIC COMA 60 0.0208
23 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 7 0.0205
24 HYPOGLYCAEMIA UNAWARENESS 7 0.0196
25 WRONG DRUG ADMINISTERED 173 0.0194
26 DIABETIC RETINOPATHY 64 0.0188
27 HYPOGLYCAEMIC SEIZURE 17 0.0187
28 DIABETIC HYPERGLYCAEMIC COMA 6 0.0184
29 HYPOGLYCAEMIC ENCEPHALOPATHY 7 0.0180
30 HYPERGLYCAEMIA 655 0.0180
31 TYPE III IMMUNE COMPLEX MEDIATED REACTION 10 0.0179
32 BLOOD GLUCOSE FLUCTUATION 188 0.0171
33 TRANSFERRIN SATURATION DECREASED 7 0.0164
34 HYPOGLYCAEMIA 785 0.0162
35 DIABETES MELLITUS INADEQUATE CONTROL 286 0.0161
36 AUTOIMMUNE PANCREATITIS 8 0.0158
37 THYROID CYST 9 0.0151
38 BLOOD GLUCOSE ABNORMAL 277 0.0150
39 TINEA INFECTION 15 0.0136
40 KETONURIA 11 0.0135
41 MONOCLONAL GAMMOPATHY 8 0.0128
42 KETOSIS 13 0.0120
43 KETOACIDOSIS 88 0.0117
44 WAIST CIRCUMFERENCE INCREASED 12 0.0116
45 DIABETIC COMA 32 0.0114
46 SYSTEMIC INFECTION 18 0.0108
47 GLYCOSYLATED HAEMOGLOBIN INCREASED 270 0.0107
48 DIABETIC FOOT 32 0.0104
49 DIABETIC KETOACIDOSIS 251 0.0104
50 BLOOD KETONE BODY INCREASED 8 0.0102
51 ENTEROCOCCAL SEPSIS 8 0.0099
52 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 8 0.0098
53 BLOOD GLUCOSE DECREASED 455 0.0095
54 TINEA PEDIS 15 0.0094
55 INSULIN RESISTANCE 19 0.0091
56 DEVICE OPERATIONAL ISSUE 39 0.0091
57 GLYCOSYLATED HAEMOGLOBIN DECREASED 14 0.0087
58 GLOMERULAR FILTRATION RATE INCREASED 7 0.0085
59 BLOOD GLUCOSE INCREASED 1577 0.0084
60 ESCHAR 6 0.0082
61 CYSTOID MACULAR OEDEMA 15 0.0080
62 URINE KETONE BODY PRESENT 12 0.0076
63 SIMPLE PARTIAL SEIZURES 6 0.0074
64 TROPONIN T INCREASED 9 0.0071
65 DIABETIC FOOT INFECTION 10 0.0071
66 PRODUCT MONITORING ERROR 10 0.0069
67 MUCOSAL HAEMORRHAGE 8 0.0069
68 SPONTANEOUS HAEMORRHAGE 7 0.0068
69 PANCREATIC MASS 7 0.0065
70 ARRHYTHMIA SUPRAVENTRICULAR 7 0.0064
71 NEONATAL RESPIRATORY DISTRESS 6 0.0064
72 DIABETIC NEPHROPATHY 14 0.0064
73 DIABETIC NEUROPATHY 31 0.0063
74 DIABETIC COMPLICATION 15 0.0059
75 POLYHYDRAMNIOS 6 0.0059
76 MULTIPLE USE OF SINGLE-USE PRODUCT 33 0.0059
77 ALLERGIC REACTION TO EXCIPIENT 10 0.0050
78 BLOOD IMMUNOGLOBULIN G INCREASED 6 0.0049
79 ATROPHY 9 0.0046
80 EXTREMITY NECROSIS 8 0.0046
81 RETINOPATHY 17 0.0046
82 DAYDREAMING 7 0.0045
83 SINUS ARREST 7 0.0045
84 POSTPARTUM HAEMORRHAGE 6 0.0045
85 GASTROINTESTINAL STOMA COMPLICATION 7 0.0045
86 SOPOR 59 0.0044
87 HYPERPARATHYROIDISM SECONDARY 11 0.0044
88 HYPOGLYCAEMIA NEONATAL 7 0.0043
89 INJECTION SITE ATROPHY 7 0.0043
90 MEAN CELL HAEMOGLOBIN INCREASED 7 0.0042
91 JAUNDICE NEONATAL 8 0.0042
92 PANCREATITIS CHRONIC 10 0.0042
93 EYE HAEMORRHAGE 56 0.0042
94 WRONG PRODUCT ADMINISTERED 28 0.0041
95 CATARACT OPERATION 24 0.0040
96 EXPIRED DRUG ADMINISTERED 20 0.0040
97 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
98 HEAT STROKE 6 0.0039
99 TOE AMPUTATION 20 0.0039
100 MACULAR OEDEMA 22 0.0039
101 ADENOCARCINOMA PANCREAS 5 0.0039
102 NEPHROGENIC ANAEMIA 18 0.0039
103 PSYCHOMOTOR SKILLS IMPAIRED 10 0.0038
104 DILATATION VENTRICULAR 8 0.0038
105 LIQUID PRODUCT PHYSICAL ISSUE 27 0.0037
106 SPINAL CORD DISORDER 6 0.0036
107 LEG AMPUTATION 15 0.0036
108 EUGLYCAEMIC DIABETIC KETOACIDOSIS 15 0.0036
109 INJECTION SITE ABSCESS 9 0.0036
110 INCORRECT STORAGE OF DRUG 6 0.0035
111 INTERNATIONAL NORMALISED RATIO FLUCTUATION 7 0.0034
112 GANGRENE 20 0.0033
113 ADHESION 5 0.0033
114 LIPODYSTROPHY ACQUIRED 7 0.0033
115 HAEMATOMA 84 0.0032
116 INFLAMMATORY MARKER INCREASED 16 0.0032
117 DRUG ADMINISTRATION ERROR 98 0.0032
118 INJECTION SITE SCAR 9 0.0032
119 VASCULAR GRAFT 9 0.0031
120 CONGESTIVE CARDIOMYOPATHY 13 0.0031
121 MEAN CELL VOLUME INCREASED 8 0.0031
122 HAEMOTHORAX 9 0.0031
123 THERMAL BURN 22 0.0031
124 PANCREATIC DISORDER 15 0.0030
125 INJECTION SITE INFECTION 10 0.0030
126 BRADYARRHYTHMIA 5 0.0030
127 EXPIRED DEVICE USED 10 0.0030
128 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
129 METABOLIC ACIDOSIS 92 0.0029
130 GASTRIC HAEMORRHAGE 33 0.0029
131 THERAPEUTIC RESPONSE DELAYED 8 0.0029
132 ANAL HAEMORRHAGE 8 0.0029
133 DECUBITUS ULCER 23 0.0028
134 PANCREATIC CARCINOMA METASTATIC 8 0.0028
135 BLOOD TESTOSTERONE INCREASED 6 0.0028
136 INFARCTION 19 0.0028
137 METABOLIC DISORDER 16 0.0028
138 HYPERKALAEMIA 94 0.0027
139 ELECTROCARDIOGRAM ABNORMAL 21 0.0027
140 ESCHERICHIA INFECTION 22 0.0027
141 ARTERIAL OCCLUSIVE DISEASE 21 0.0027
142 INCORRECT PRODUCT STORAGE 35 0.0027
143 DISTRIBUTIVE SHOCK 6 0.0026
144 DENGUE FEVER 6 0.0026
145 AORTIC STENOSIS 9 0.0026
146 KLEBSIELLA INFECTION 13 0.0026
147 URINARY INCONTINENCE 76 0.0026
148 EXPIRED PRODUCT ADMINISTERED 83 0.0025
149 RENAL TRANSPLANT 9 0.0025
150 VITAMIN B12 DEFICIENCY 10 0.0025
151 BACTERIAL SEPSIS 8 0.0025
152 DYSPNOEA AT REST 7 0.0024
153 ERYSIPELAS 12 0.0024
154 OCULAR ICTERUS 10 0.0023
155 ISCHAEMIC CARDIOMYOPATHY 7 0.0023
156 ENTEROCOLITIS 13 0.0022
157 INJECTION SITE HYPERSENSITIVITY 7 0.0022
158 CONTRAINDICATED PRODUCT ADMINISTERED 67 0.0022
159 INJECTION SITE INFLAMMATION 11 0.0022
160 VISUAL ACUITY REDUCED 73 0.0022
161 VITREOUS HAEMORRHAGE 6 0.0022
162 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
163 TYPE 1 DIABETES MELLITUS 13 0.0022
164 THIRST 38 0.0021
165 SNORING 8 0.0021
166 RETINAL HAEMORRHAGE 15 0.0021
167 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
168 PHARYNGEAL DISORDER 6 0.0021
169 OESOPHAGEAL DISORDER 8 0.0021
170 WOUND COMPLICATION 7 0.0020
171 ACUTE KIDNEY INJURY 310 0.0020
172 POLYDIPSIA 8 0.0020
173 BLOOD CULTURE POSITIVE 6 0.0020
174 TYPE I HYPERSENSITIVITY 7 0.0020
175 LOCALISED INFECTION 48 0.0020
176 CATARACT 118 0.0020
177 LACTIC ACIDOSIS 64 0.0020
178 PROSTATITIS 6 0.0020
179 BLINDNESS 80 0.0020
180 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 8 0.0020
181 DIZZINESS POSTURAL 19 0.0020
182 VISUAL IMPAIRMENT 242 0.0020
183 ENDOCARDITIS 10 0.0019
184 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
185 CEREBRAL ISCHAEMIA 10 0.0019
186 HUNGER 27 0.0019
187 SPINAL STENOSIS 8 0.0019
188 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
189 TONSILLITIS 10 0.0019
190 ACUTE MYOCARDIAL INFARCTION 56 0.0019
191 NEPHROTIC SYNDROME 13 0.0019
192 BUNDLE BRANCH BLOCK LEFT 8 0.0019
193 ATRIAL FLUTTER 15 0.0019
194 RENAL FAILURE 249 0.0019
195 EXTRASYSTOLES 13 0.0019
196 PRODUCT STORAGE ERROR 163 0.0019
197 HYPERHIDROSIS 238 0.0018
198 FACE INJURY 7 0.0018
199 EXPOSURE DURING BREAST FEEDING 6 0.0018
200 PANCREATIC CARCINOMA 52 0.0018
201 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
202 POTENTIATING DRUG INTERACTION 6 0.0018
203 DISABILITY 35 0.0018
204 COLD SWEAT 31 0.0018
205 END STAGE RENAL DISEASE 32 0.0018
206 ANURIA 15 0.0017
207 RETINAL DETACHMENT 16 0.0017
208 UROSEPSIS 16 0.0017
209 URINE OUTPUT DECREASED 15 0.0017
210 GOITRE 7 0.0017
211 BLINDNESS UNILATERAL 24 0.0017
212 HYPERCHLORHYDRIA 10 0.0017
213 RENAL FAILURE CHRONIC 13 0.0017
214 IMPAIRED GASTRIC EMPTYING 23 0.0017
215 CARDIAC FAILURE CHRONIC 7 0.0016
216 PRODUCT QUALITY ISSUE 223 0.0016
217 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
218 LOSS OF CONSCIOUSNESS 209 0.0016
219 RENAL TUBULAR NECROSIS 16 0.0016
220 CARDIAC OPERATION 14 0.0016
221 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
222 HYPERTENSIVE CRISIS 18 0.0016
223 NEPHROPATHY 15 0.0016
224 HYPERNATRAEMIA 8 0.0016
225 HAEMORRHAGIC ANAEMIA 7 0.0016
226 SYNCOPE 159 0.0016
227 POLYNEUROPATHY 19 0.0016
228 PULMONARY OEDEMA 71 0.0016
229 ACIDOSIS 12 0.0016
230 SCIATICA 25 0.0016
231 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
232 FOETAL DEATH 8 0.0015
233 COGNITIVE DISORDER 72 0.0015
234 APNOEA 12 0.0015
235 PARTIAL SEIZURES 8 0.0015
236 BRADYKINESIA 9 0.0015
237 FURUNCLE 12 0.0015
238 RENAL FUNCTION TEST ABNORMAL 7 0.0015
239 MACULAR DEGENERATION 18 0.0015
240 HYPERPHAGIA 6 0.0015
241 PYELONEPHRITIS 13 0.0015
242 DIARRHOEA HAEMORRHAGIC 14 0.0015
243 BLOOD POTASSIUM INCREASED 24 0.0015
244 SHOCK HAEMORRHAGIC 12 0.0015
245 SKIN ULCER 38 0.0015
246 PEMPHIGOID 11 0.0015
247 CHOLANGITIS 9 0.0015
248 HUMERUS FRACTURE 7 0.0015
249 HYPERKERATOSIS 8 0.0014
250 OLIGURIA 9 0.0014
251 BLOOD CREATININE ABNORMAL 5 0.0014
252 NECROSIS 8 0.0014
253 GENERAL PHYSICAL HEALTH DETERIORATION 166 0.0014
254 INJURY ASSOCIATED WITH DEVICE 29 0.0014
255 PREMATURE LABOUR 8 0.0014
256 ABSCESS LIMB 6 0.0014
257 INTERVERTEBRAL DISC DISORDER 6 0.0014
258 EYE DISORDER 46 0.0014
259 EXERCISE TOLERANCE DECREASED 8 0.0014
260 APPARENT DEATH 5 0.0014
261 INJECTION SITE HAEMATOMA 20 0.0014
262 BLOOD UREA INCREASED 23 0.0014
263 SPINAL PAIN 16 0.0014
264 BLOOD CREATINE INCREASED 6 0.0014
265 VARICOSE VEIN 7 0.0014
266 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
267 PSYCHOTIC DISORDER 40 0.0014
268 DEVICE MALFUNCTION 95 0.0014
269 GLAUCOMA 26 0.0013
270 WHEELCHAIR USER 6 0.0013
271 CARDIAC DYSFUNCTION 5 0.0013
272 POLYURIA 11 0.0013
273 CARDIOVASCULAR DISORDER 34 0.0013
274 HEARING IMPAIRED 8 0.0013
275 THROMBOTIC MICROANGIOPATHY 13 0.0013
276 ACUTE CORONARY SYNDROME 11 0.0013
277 MELAENA 29 0.0013
278 SENSORY DISTURBANCE 21 0.0013
279 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
280 PRODUCT PRESCRIBING ERROR 31 0.0013
281 NERVE COMPRESSION 12 0.0013
282 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
283 ANKLE FRACTURE 20 0.0013
284 ANGINA PECTORIS 37 0.0013
285 DIALYSIS 18 0.0013
286 FOOT FRACTURE 24 0.0013
287 MUSCLE ATROPHY 16 0.0013
288 MEDICATION ERROR 70 0.0013
289 AZOTAEMIA 5 0.0013
290 LIMB OPERATION 6 0.0012
291 RENAL DISORDER 58 0.0012
292 COMA 59 0.0012
293 DEPRESSED LEVEL OF CONSCIOUSNESS 49 0.0012
294 DRUG EXPOSURE DURING PREGNANCY 42 0.0012
295 HEPATITIS ACUTE 8 0.0012
296 APPLICATION SITE DISCOLOURATION 5 0.0012
297 BRADYPHRENIA 8 0.0012
298 ASCITES 36 0.0012
299 BLINDNESS TRANSIENT 9 0.0012
300 BODY TEMPERATURE DECREASED 12 0.0012
301 FOOT OPERATION 6 0.0012
302 HYPERVENTILATION 7 0.0012
303 CORONARY ARTERY STENOSIS 6 0.0012
304 HAEMODIALYSIS 10 0.0012
305 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
306 INJECTION SITE NODULE 13 0.0012
307 LIPASE INCREASED 9 0.0012
308 HYPERLIPIDAEMIA 14 0.0012
309 ARTERIOSCLEROSIS 11 0.0012
310 PERIPHERAL VASCULAR DISORDER 6 0.0012
311 BLOOD PRESSURE INADEQUATELY CONTROLLED 7 0.0012
312 CEREBROVASCULAR ACCIDENT 197 0.0012
313 CARDIAC FAILURE 93 0.0012
314 OEDEMA PERIPHERAL 141 0.0012
315 PLATELET COUNT INCREASED 15 0.0011
316 BONE CANCER 5 0.0011
317 HYPOMAGNESAEMIA 16 0.0011
318 BLOOD CREATININE INCREASED 75 0.0011
319 GASTROINTESTINAL HAEMORRHAGE 96 0.0011
320 CARDIO-RESPIRATORY ARREST 48 0.0011
321 MASS 16 0.0011
322 ERUCTATION 22 0.0011
323 NERVOUSNESS 59 0.0011
324 HAND FRACTURE 8 0.0011
325 CATHETERISATION CARDIAC 5 0.0011
326 BALANCE DISORDER 97 0.0011
327 ISCHAEMIC STROKE 20 0.0011
328 INJECTION SITE DISCOLOURATION 14 0.0011
329 COMPRESSION FRACTURE 6 0.0011
330 ELECTROLYTE IMBALANCE 13 0.0011
331 SENSORY LOSS 9 0.0011
332 PANCREATITIS 59 0.0011
333 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
334 DIABETES MELLITUS 84 0.0011
335 SLEEP APNOEA SYNDROME 21 0.0011
336 ROAD TRAFFIC ACCIDENT 46 0.0011
337 EXPOSURE DURING PREGNANCY 68 0.0011
338 PRODUCT ADMINISTRATION ERROR 22 0.0011
339 RESPIRATORY DISTRESS 30 0.0011
340 GASTRIC ULCER HAEMORRHAGE 6 0.0011
341 INJECTION SITE INJURY 6 0.0011
342 INCOHERENT 7 0.0011
343 ANGINA UNSTABLE 7 0.0011
344 LYMPHOCYTE COUNT DECREASED 19 0.0011
345 TENDON DISORDER 7 0.0011
346 WOUND 30 0.0011
347 DEHYDRATION 143 0.0011
348 CELLULITIS 54 0.0011
349 SPEECH DISORDER 56 0.0011
350 LIMB INJURY 29 0.0011
351 HAEMATEMESIS 27 0.0011
352 CORONARY ARTERY DISEASE 32 0.0011
353 FACIAL PARALYSIS 9 0.0011
354 PROTEINURIA 20 0.0011
355 CARDIAC FAILURE ACUTE 7 0.0010
356 VISION BLURRED 144 0.0010
357 SKIN MASS 7 0.0010
358 HYPERTHERMIA 8 0.0010
359 LOWER LIMB FRACTURE 20 0.0010
360 MUSCLE STRAIN 9 0.0010
361 POSTOPERATIVE WOUND INFECTION 7 0.0010
362 PREMATURE BABY 31 0.0010
363 DEVICE USE ISSUE 18 0.0010
364 GASTROENTERITIS 15 0.0010
365 CHRONIC KIDNEY DISEASE 78 0.0010
366 VITAMIN D DEFICIENCY 10 0.0010
367 HYPERTRIGLYCERIDAEMIA 6 0.0010
368 HAEMORRHAGIC STROKE 8 0.0010
369 TREMOR 170 0.0010
370 URINE ODOUR ABNORMAL 6 0.0010
371 KIDNEY INFECTION 20 0.0010
372 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
373 ANAEMIA 194 0.0010
374 RENAL FAILURE ACUTE 43 0.0010
375 PRODUCT DOSE OMISSION 66 0.0010
376 INABILITY TO AFFORD MEDICATION 10 0.0010
377 ASPIRATION 11 0.0010
378 PRESCRIBED UNDERDOSE 20 0.0010
379 CONFUSIONAL STATE 162 0.0010
380 PALLOR 27 0.0010
381 INCORRECT DOSE ADMINISTERED BY DEVICE 26 0.0010
382 NERVE INJURY 11 0.0010
383 NOCTURIA 12 0.0010
384 SEPTIC SHOCK 43 0.0010
385 RHABDOMYOLYSIS 41 0.0010
386 SUBDURAL HAEMATOMA 14 0.0010
387 NEUTROPHIL COUNT INCREASED 10 0.0010
388 LARYNGEAL OEDEMA 6 0.0010
389 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
390 LYMPHOMA 15 0.0010
391 HAEMOPTYSIS 27 0.0010
392 HEPATIC STEATOSIS 18 0.0010
393 DEMENTIA 27 0.0010
394 APPENDICITIS 9 0.0010
395 VENTRICULAR EXTRASYSTOLES 10 0.0010
396 HEAD DISCOMFORT 17 0.0010
397 HEPATIC CIRRHOSIS 18 0.0010
398 WEIGHT FLUCTUATION 10 0.0010
399 SPINAL DISORDER 9 0.0009
400 TRANSIENT ISCHAEMIC ATTACK 32 0.0009
401 INJECTION SITE MASS 35 0.0009
402 RENAL IMPAIRMENT 79 0.0009
403 THERAPEUTIC RESPONSE DECREASED 57 0.0009
404 INTENTIONAL PRODUCT MISUSE 82 0.0009
405 POLLAKIURIA 39 0.0009
406 COVID-19 PNEUMONIA 11 0.0009
407 HYPOACUSIS 40 0.0009
408 NEUROPATHY PERIPHERAL 88 0.0009
409 URINARY TRACT INFECTION 157 0.0009
410 BACK INJURY 10 0.0009
411 BRONCHITIS 68 0.0009
412 VITREOUS FLOATERS 9 0.0009
413 CHOLELITHIASIS 30 0.0009
414 MYOCARDIAL INFARCTION 159 0.0009
415 MALAISE 398 0.0009
416 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
417 HYPONATRAEMIA 51 0.0009
418 PURPURA 8 0.0009
419 UPPER LIMB FRACTURE 18 0.0009
420 LIVER DISORDER 40 0.0009
421 CYTOPENIA 11 0.0009
422 DYSURIA 33 0.0009
423 BREAST MASS 6 0.0009
424 GOUT 16 0.0009
425 JOINT INJURY 19 0.0009
426 HYPOTHERMIA 9 0.0009
427 WEIGHT INCREASED 198 0.0009
428 DEVICE ISSUE 79 0.0009
429 FAECES DISCOLOURED 19 0.0009
430 DRUG INTERACTION 139 0.0009
431 EXOSTOSIS 8 0.0009
432 BLOOD URIC ACID INCREASED 5 0.0009
433 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 156 0.0009
434 HYPOAESTHESIA ORAL 13 0.0009
435 AGGRESSION 43 0.0009
436 DISORIENTATION 34 0.0009
437 ASPHYXIA 7 0.0009
438 BURNING SENSATION 60 0.0009
439 GAIT DISTURBANCE 163 0.0009
440 LACERATION 8 0.0008
441 DRUG DISPENSING ERROR 13 0.0008
442 HIATUS HERNIA 11 0.0008
443 INJECTION SITE INDURATION 11 0.0008
444 ACCIDENTAL OVERDOSE 31 0.0008
445 EATING DISORDER 18 0.0008
446 DIVERTICULUM 6 0.0008
447 EMBOLISM 7 0.0008
448 HEMIPLEGIA 7 0.0008
449 HEART RATE IRREGULAR 19 0.0008
450 CARDIAC PACEMAKER INSERTION 5 0.0008
451 BEDRIDDEN 11 0.0008
452 PRURITUS GENERALISED 18 0.0008
453 ACUTE RESPIRATORY FAILURE 16 0.0008
454 DERMATITIS BULLOUS 6 0.0008
455 HYPERCHOLESTEROLAEMIA 8 0.0008
456 OSTEOMYELITIS 15 0.0008
457 ATELECTASIS 8 0.0008
458 FALL 272 0.0008
459 HYPERTENSION 173 0.0008
460 DIZZINESS 407 0.0008
461 CHEST PAIN 151 0.0008
462 HEPATOMEGALY 8 0.0008
463 CARDIAC DISORDER 76 0.0008
464 ASTHENIA 305 0.0008
465 VENTRICULAR FIBRILLATION 9 0.0008
466 CEREBRAL HAEMORRHAGE 29 0.0008
467 RASH MACULO-PAPULAR 18 0.0008
468 LIGAMENT SPRAIN 8 0.0008
469 KNEE ARTHROPLASTY 17 0.0008
470 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
471 BLADDER DISORDER 8 0.0008
472 ACUTE HEPATIC FAILURE 11 0.0008
473 CORONARY ARTERY OCCLUSION 11 0.0008
474 HYPOTONIA 8 0.0008
475 PANCREATITIS ACUTE 18 0.0008
476 NAIL DISORDER 7 0.0008
477 SPINAL OSTEOARTHRITIS 7 0.0008
478 TOXIC SKIN ERUPTION 8 0.0008
479 UNEVALUABLE EVENT 60 0.0008
480 DRUG ERUPTION 14 0.0008
481 EXTRA DOSE ADMINISTERED 32 0.0008
482 GASTRIC ULCER 15 0.0008
483 INJECTION SITE HAEMORRHAGE 63 0.0008
484 CHOLECYSTECTOMY 9 0.0008
485 SUBARACHNOID HAEMORRHAGE 8 0.0008
486 SLUGGISHNESS 8 0.0008
487 PROCEDURAL COMPLICATION 6 0.0008
488 CONTUSION 75 0.0008
489 ATRIOVENTRICULAR BLOCK 6 0.0008
490 SEPSIS 86 0.0008
491 PELVIC FRACTURE 6 0.0008
492 WEIGHT DECREASED 215 0.0008
493 PARALYSIS 11 0.0008
494 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
495 PERIPHERAL SWELLING 118 0.0008
496 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
497 HYPOTENSION 152 0.0008
498 SUDDEN DEATH 8 0.0008
499 MUSCULOSKELETAL DISCOMFORT 13 0.0008
500 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
501 BLOOD PRESSURE ABNORMAL 15 0.0008
502 WRIST FRACTURE 9 0.0008
503 BACTERIAL INFECTION 14 0.0007
504 HEPATIC ENCEPHALOPATHY 7 0.0007
505 FLANK PAIN 7 0.0007
506 STENT PLACEMENT 6 0.0007
507 PLASMA CELL MYELOMA 29 0.0007
508 JAUNDICE 20 0.0007
509 EOSINOPHILIA 13 0.0007
510 VOMITING 348 0.0007
511 FEEDING DISORDER 15 0.0007
512 INTENTIONAL DOSE OMISSION 21 0.0007
513 BIPOLAR DISORDER 8 0.0007
514 CARDIAC FAILURE CONGESTIVE 59 0.0007
515 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
516 BLOOD TESTOSTERONE DECREASED 5 0.0007
517 GENERALISED OEDEMA 9 0.0007
518 HEAD INJURY 23 0.0007
519 VENTRICULAR TACHYCARDIA 12 0.0007
520 SPINAL COMPRESSION FRACTURE 6 0.0007
521 GASTRITIS 19 0.0007
522 MALNUTRITION 8 0.0007
523 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
524 SKIN PLAQUE 6 0.0007
525 DECREASED APPETITE 165 0.0007
526 HEMIPARESIS 12 0.0007
527 EJECTION FRACTION DECREASED 11 0.0007
528 PLEURAL EFFUSION 43 0.0007
529 VERTIGO 43 0.0007
530 CIRCULATORY COLLAPSE 12 0.0007
531 SCAB 8 0.0007
532 ALANINE AMINOTRANSFERASE INCREASED 43 0.0007
533 INTERNAL HAEMORRHAGE 8 0.0007
534 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
535 RESPIRATORY FAILURE 51 0.0007
536 FIBROMYALGIA 17 0.0007
537 CEREBRAL INFARCTION 17 0.0007
538 DYSPNOEA 393 0.0007
539 PRODUCT USE ISSUE 130 0.0007
540 HYPERTHYROIDISM 10 0.0007
541 ABSCESS 11 0.0007
542 ORTHOSTATIC HYPOTENSION 12 0.0007
543 TOOTH ABSCESS 7 0.0007
544 VASCULITIS 8 0.0007
545 FEELING HOT 42 0.0007
546 DRUG DOSE OMISSION 113 0.0007
547 PULMONARY CONGESTION 9 0.0007
548 OEDEMA 37 0.0007
549 BRADYCARDIA 36 0.0007
550 FEELING ABNORMAL 162 0.0007
551 CEREBRAL DISORDER 5 0.0007
552 BACTERAEMIA 8 0.0007
553 EYE PAIN 38 0.0007
554 PNEUMONIA 218 0.0007
555 INFLUENZA 75 0.0007
556 GASTROINTESTINAL INFECTION 6 0.0007
557 PRODUCT ODOUR ABNORMAL 7 0.0007
558 ANAL INCONTINENCE 6 0.0007
559 THYROID CANCER 8 0.0007
560 GASTROENTERITIS VIRAL 12 0.0007
561 LEUKOCYTOSIS 12 0.0007
562 DELIRIUM 23 0.0007
563 JOINT DISLOCATION 7 0.0007
564 ABDOMINAL DISTENSION 69 0.0007
565 AMNESIA 43 0.0007
566 INTERSTITIAL LUNG DISEASE 32 0.0007
567 PRESYNCOPE 16 0.0007
568 RASH GENERALISED 17 0.0007
569 PERIPHERAL COLDNESS 9 0.0007
570 CENTRAL NERVOUS SYSTEM LESION 9 0.0007
571 PERICARDITIS 11 0.0007
572 HIP FRACTURE 21 0.0007
573 IRON DEFICIENCY ANAEMIA 6 0.0006
574 SPINAL OPERATION 8 0.0006
575 THYROID DISORDER 10 0.0006
576 INJECTION SITE EXTRAVASATION 8 0.0006
577 PAIN IN EXTREMITY 191 0.0006
578 HOSPITALISATION 99 0.0006
579 ILEUS 8 0.0006
580 OESOPHAGITIS 7 0.0006
581 SQUAMOUS CELL CARCINOMA 6 0.0006
582 DERMATITIS ALLERGIC 8 0.0006
583 HEPATOCELLULAR INJURY 9 0.0006
584 ARRHYTHMIA 30 0.0006
585 DYSPEPSIA 62 0.0006
586 APHASIA 19 0.0006
587 AMENORRHOEA 11 0.0006
588 INJECTION SITE BRUISING 50 0.0006
589 CHOLESTASIS 12 0.0006
590 DRUG PRESCRIBING ERROR 12 0.0006
591 PULMONARY HYPERTENSION 13 0.0006
592 BLOOD DISORDER 5 0.0006
593 FISTULA 7 0.0006
594 BLOOD CALCIUM DECREASED 7 0.0006
595 TREATMENT NONCOMPLIANCE 34 0.0006
596 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29 0.0006
597 SKIN LESION 17 0.0006
598 PHARMACEUTICAL PRODUCT COMPLAINT 16 0.0006
599 MYOCARDIAL ISCHAEMIA 7 0.0006
600 BACK DISORDER 10 0.0006
601 RESPIRATORY TRACT INFECTION 16 0.0006
602 OSTEOARTHRITIS 26 0.0006
603 COELIAC DISEASE 6 0.0006
604 DYSPNOEA EXERTIONAL 23 0.0006
605 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
606 SKIN HAEMORRHAGE 9 0.0006
607 MUSCULAR WEAKNESS 69 0.0006
608 ABDOMINAL PAIN UPPER 125 0.0006
609 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
610 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
611 COUGH 169 0.0006
612 INFLAMMATION 31 0.0006
613 CONDITION AGGRAVATED 182 0.0006
614 SWELLING 56 0.0006
615 ATRIAL SEPTAL DEFECT 5 0.0006
616 FEAR 16 0.0006
617 FACE OEDEMA 10 0.0006
618 DEVICE FAILURE 9 0.0006
619 BLOOD PRESSURE INCREASED 90 0.0006
620 NEPHROLITHIASIS 27 0.0006
621 EUPHORIC MOOD 6 0.0006
622 DYSARTHRIA 22 0.0006
623 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
624 DEVICE MECHANICAL ISSUE 8 0.0006
625 RIB FRACTURE 12 0.0006
626 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
627 BLOOD URINE PRESENT 11 0.0006
628 BLOOD MAGNESIUM DECREASED 5 0.0006
629 LUNG INFECTION 9 0.0006
630 NASAL CONGESTION 34 0.0006
631 MULTI-ORGAN FAILURE 10 0.0006
632 CARDIAC MURMUR 5 0.0006
633 C-REACTIVE PROTEIN INCREASED 21 0.0006
634 BURSITIS 7 0.0006
635 BASAL CELL CARCINOMA 9 0.0006
636 INCREASED APPETITE 11 0.0006
637 ATRIAL FIBRILLATION 56 0.0006
638 FEELING COLD 16 0.0006
639 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
640 SEDATION 15 0.0006
641 RASH PRURITIC 31 0.0006
642 INJECTION SITE DISCOMFORT 6 0.0006
643 ENCEPHALOPATHY 14 0.0006
644 SCRATCH 6 0.0006
645 TENDON RUPTURE 7 0.0006
646 HYPERCALCAEMIA 7 0.0006
647 TYPE 2 DIABETES MELLITUS 19 0.0006
648 CHOKING 11 0.0006
649 SINUS TACHYCARDIA 8 0.0006
650 PNEUMONIA ASPIRATION 14 0.0006
651 HEREDITARY ANGIOEDEMA 6 0.0006
652 HYPOKINESIA 8 0.0006
653 PRODUCT DISPENSING ERROR 12 0.0006
654 INTRAOCULAR PRESSURE INCREASED 7 0.0005
655 STAPHYLOCOCCAL INFECTION 18 0.0005
656 BRAIN NEOPLASM 5 0.0005
657 HYPOKALAEMIA 25 0.0005
658 DIVERTICULITIS 15 0.0005
659 HEPATIC CANCER 13 0.0005
660 PYREXIA 187 0.0005
661 MENTAL STATUS CHANGES 15 0.0005
662 SKIN DISORDER 18 0.0005
663 GAIT INABILITY 18 0.0005
664 COLON CANCER 8 0.0005
665 DEAFNESS 14 0.0005
666 BLOOD POTASSIUM DECREASED 16 0.0005
667 TOOTH INFECTION 7 0.0005
668 FLUID RETENTION 27 0.0005
669 BLOOD SODIUM DECREASED 10 0.0005
670 SURGERY 31 0.0005
671 PLATELET COUNT DECREASED 56 0.0005
672 HEART RATE INCREASED 52 0.0005
673 NEOPLASM MALIGNANT 35 0.0005
674 EPILEPSY 16 0.0005
675 NEOPLASM 6 0.0005
676 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
677 PERICARDIAL EFFUSION 12 0.0005
678 IMPAIRED HEALING 17 0.0005
679 LIMB DISCOMFORT 16 0.0005
680 FEMUR FRACTURE 16 0.0005
681 SOMNOLENCE 104 0.0005
682 BLISTER 29 0.0005
683 INJECTION SITE PAIN 158 0.0005
684 METASTASES TO LIVER 9 0.0005
685 DEPRESSED MOOD 27 0.0005
686 URINARY RETENTION 17 0.0005
687 HEPATIC FUNCTION ABNORMAL 19 0.0005
688 HEPATITIS 13 0.0005
689 PRODUCT USE COMPLAINT 8 0.0005
690 ANAPHYLACTIC REACTION 28 0.0005
691 BLOOD IRON DECREASED 6 0.0005
692 ULCER 8 0.0005
693 ACCIDENT 6 0.0005
694 SKIN DISCOLOURATION 23 0.0005
695 CHEST DISCOMFORT 51 0.0005
696 DEVICE OCCLUSION 7 0.0005
697 HEPATITIS C 6 0.0005
698 URTICARIA 83 0.0005
699 MEMORY IMPAIRMENT 68 0.0005
700 ABDOMINAL PAIN 114 0.0005
701 INJECTION SITE URTICARIA 12 0.0005
702 CARDIOGENIC SHOCK 7 0.0005
703 ABASIA 12 0.0005
704 PHARYNGITIS 6 0.0005
705 PERITONITIS 10 0.0005
706 NAUSEA 380 0.0005
707 DYSSTASIA 14 0.0005
708 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
709 SUICIDE ATTEMPT 29 0.0005
710 MOOD ALTERED 13 0.0005
711 PULMONARY EMBOLISM 45 0.0005
712 TACHYCARDIA 42 0.0005
713 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
714 FEELING JITTERY 9 0.0005
715 RENAL INJURY 14 0.0005
716 HAEMATOCHEZIA 26 0.0005
717 CYSTITIS 15 0.0005
718 PULMONARY MASS 7 0.0005
719 HYPOPHAGIA 12 0.0005
720 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
721 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17 0.0005
722 HYPOAESTHESIA 70 0.0005
723 ADVERSE DRUG REACTION 42 0.0005
724 BODY HEIGHT DECREASED 5 0.0005
725 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
726 SCAR 8 0.0005
727 ROTATOR CUFF SYNDROME 6 0.0005
728 MOVEMENT DISORDER 15 0.0005
729 BLOOD PRESSURE DECREASED 31 0.0005
730 GASTRIC DISORDER 16 0.0005
731 NEUTROPHIL COUNT DECREASED 19 0.0005
732 PRURITUS 179 0.0005
733 MYALGIA 79 0.0005
734 ECONOMIC PROBLEM 7 0.0005
735 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
736 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
737 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
738 LOCAL SWELLING 8 0.0005
739 PAIN 281 0.0005
740 INFECTION 66 0.0005
741 DIARRHOEA 294 0.0005
742 SINUS DISORDER 9 0.0005
743 EMOTIONAL DISORDER 14 0.0005
744 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
745 HYPERSENSITIVITY 84 0.0005
746 MUSCULOSKELETAL CHEST PAIN 7 0.0005
747 ARTHROPATHY 25 0.0004
748 NERVOUS SYSTEM DISORDER 14 0.0004
749 HAEMOGLOBIN DECREASED 46 0.0004
750 THROMBOSIS 36 0.0004
751 MOBILITY DECREASED 32 0.0004
752 DISCOMFORT 27 0.0004
753 UVEITIS 6 0.0004
754 DRUG INEFFECTIVE 582 0.0004
755 FLATULENCE 25 0.0004
756 PREMATURE DELIVERY 7 0.0004
757 OBESITY 7 0.0004
758 SLEEP DISORDER 31 0.0004
759 HYPOTHYROIDISM 14 0.0004
760 DEVICE LEAKAGE 19 0.0004
761 LUNG NEOPLASM MALIGNANT 18 0.0004
762 CHILLS 51 0.0004
763 MUSCLE TWITCHING 10 0.0004
764 ARTHRITIS 34 0.0004
765 PARAESTHESIA 68 0.0004
766 CAESAREAN SECTION 5 0.0004
767 PANCYTOPENIA 24 0.0004
768 NASOPHARYNGITIS 79 0.0004
769 LUNG DISORDER 21 0.0004
770 UNRESPONSIVE TO STIMULI 11 0.0004
771 HEADACHE 266 0.0004
772 CARDIAC ARREST 35 0.0004
773 HYPOCALCAEMIA 8 0.0004
774 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
775 IMPAIRED WORK ABILITY 9 0.0004
776 CONVULSION 24 0.0004
777 DRY MOUTH 34 0.0004
778 RECTAL HAEMORRHAGE 18 0.0004
779 BACK PAIN 97 0.0004
780 CANDIDA INFECTION 7 0.0004
781 MUSCLE SPASMS 76 0.0004
782 ADRENAL INSUFFICIENCY 5 0.0004
783 NEURALGIA 10 0.0004
784 ORAL HERPES 8 0.0004
785 FEBRILE NEUTROPENIA 27 0.0004
786 NIGHT SWEATS 13 0.0004
787 HAEMORRHAGE INTRACRANIAL 6 0.0004
788 MUSCULOSKELETAL PAIN 21 0.0004
789 FATIGUE 310 0.0004
790 HEPATIC FAILURE 12 0.0004
791 PRODUCTIVE COUGH 19 0.0004
792 HYPOXIA 14 0.0004
793 GASTRIC CANCER 10 0.0004
794 ERYTHEMA 81 0.0004
795 ABDOMINAL DISCOMFORT 66 0.0004
796 GALLBLADDER DISORDER 7 0.0004
797 OXYGEN SATURATION DECREASED 22 0.0004
798 INJECTION SITE RASH 12 0.0004
799 PHARYNGEAL OEDEMA 6 0.0004
800 DEVICE RELATED INFECTION 6 0.0004
801 WHEEZING 23 0.0004
802 ANAPHYLACTIC SHOCK 10 0.0004
803 RHINORRHOEA 25 0.0004
804 BLOOD CHOLESTEROL INCREASED 18 0.0004
805 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
806 THERAPY PARTIAL RESPONDER 6 0.0004
807 ANGIOEDEMA 17 0.0004
808 PALPITATIONS 45 0.0004
809 HAEMORRHAGE 40 0.0004
810 RESTLESSNESS 14 0.0004
811 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
812 ADVERSE EVENT 35 0.0004
813 HALLUCINATION, VISUAL 8 0.0004
814 ILL-DEFINED DISORDER 23 0.0004
815 PNEUMOTHORAX 6 0.0004
816 INJECTION SITE REACTION 26 0.0004
817 EYE SWELLING 14 0.0004
818 RETCHING 8 0.0004
819 ABORTION SPONTANEOUS 15 0.0004
820 PHOTOPHOBIA 7 0.0004
821 POOR QUALITY SLEEP 8 0.0004
822 ASTHMA 42 0.0004
823 CONSTIPATION 81 0.0004
824 TINNITUS 17 0.0004
825 UNDERDOSE 27 0.0004
826 SWELLING FACE 24 0.0004
827 MENTAL DISORDER 16 0.0004
828 PRODUCT PRESCRIBING ISSUE 8 0.0004
829 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
830 OVERDOSE 79 0.0004
831 PULMONARY FIBROSIS 7 0.0004
832 POST PROCEDURAL COMPLICATION 7 0.0004
833 PHOTOSENSITIVITY REACTION 6 0.0004
834 DRUG LEVEL INCREASED 6 0.0004
835 EPISTAXIS 27 0.0004
836 FUNGAL INFECTION 12 0.0004
837 DYSPHONIA 21 0.0004
838 APHONIA 5 0.0004
839 NECK PAIN 20 0.0004
840 CARPAL TUNNEL SYNDROME 5 0.0004
841 DEPRESSION 81 0.0004
842 ABDOMINAL PAIN LOWER 9 0.0004
843 SEIZURE 41 0.0004
844 DEEP VEIN THROMBOSIS 23 0.0004
845 INJECTION SITE SWELLING 27 0.0004
846 DISTURBANCE IN ATTENTION 19 0.0004
847 PRODUCT PHYSICAL ISSUE 7 0.0003
848 DIPLOPIA 9 0.0003
849 DEVICE DEFECTIVE 6 0.0003
850 INCORRECT DOSE ADMINISTERED 79 0.0003
851 TASTE DISORDER 7 0.0003
852 DYSKINESIA 14 0.0003
853 INJECTION SITE PRURITUS 23 0.0003
854 DRUG INTOLERANCE 33 0.0003
855 LEUKOPENIA 17 0.0003
856 EAR INFECTION 9 0.0003
857 TOOTH LOSS 7 0.0003
858 THROAT IRRITATION 15 0.0003
859 PAIN OF SKIN 9 0.0003
860 BLOOD BILIRUBIN INCREASED 9 0.0003
861 JOINT SWELLING 40 0.0003
862 INJECTION SITE ERYTHEMA 41 0.0003
863 RASH 144 0.0003
864 ABNORMAL BEHAVIOUR 13 0.0003
865 SUICIDAL IDEATION 30 0.0003
866 INJURY 23 0.0003
867 ABNORMAL DREAMS 9 0.0003
868 ECZEMA 17 0.0003
869 ARTHRALGIA 135 0.0003
870 EXTRAPYRAMIDAL DISORDER 8 0.0003
871 THINKING ABNORMAL 6 0.0003
872 MUSCULOSKELETAL STIFFNESS 28 0.0003
873 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
874 FRACTURE 6 0.0003
875 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
876 MUSCULOSKELETAL DISORDER 6 0.0003
877 STEVENS-JOHNSON SYNDROME 7 0.0003
878 HEART RATE DECREASED 11 0.0003
879 THROMBOCYTOPENIA 35 0.0003
880 LETHARGY 18 0.0003
881 ERECTILE DYSFUNCTION 8 0.0003
882 DRUG RESISTANCE 8 0.0003
883 HERNIA 6 0.0003
884 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
885 EXPOSURE VIA SKIN CONTACT 8 0.0003
886 OFF LABEL USE 269 0.0003
887 BLADDER CANCER 18 0.0003
888 CRYING 11 0.0003
889 SINUSITIS 31 0.0003
890 ILLNESS 31 0.0003
891 RESPIRATORY DISORDER 9 0.0003
892 SPINAL FRACTURE 6 0.0003
893 PRODUCT DOSE OMISSION ISSUE 88 0.0003
894 FREQUENT BOWEL MOVEMENTS 8 0.0003
895 HEPATIC ENZYME INCREASED 20 0.0003
896 RASH ERYTHEMATOUS 14 0.0003
897 HAEMATURIA 10 0.0003
898 HALLUCINATION 22 0.0003
899 INTESTINAL OBSTRUCTION 11 0.0003
900 INJECTION SITE WARMTH 6 0.0003
901 OROPHARYNGEAL PAIN 27 0.0003
902 SWOLLEN TONGUE 9 0.0003
903 DERMATITIS 6 0.0003
904 RASH MACULAR 10 0.0003
905 AGITATION 21 0.0003
906 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
907 MOUTH ULCERATION 6 0.0003
908 DYSPHAGIA 27 0.0003
909 DYSGEUSIA 21 0.0003
910 COVID-19 49 0.0003
911 HOT FLUSH 21 0.0003
912 HERPES ZOSTER 16 0.0003
913 PRODUCT USE IN UNAPPROVED INDICATION 69 0.0003
914 BONE PAIN 16 0.0003
915 RHEUMATOID ARTHRITIS 31 0.0003
916 SKIN EXFOLIATION 23 0.0003
917 APPLICATION SITE PAIN 6 0.0003
918 GLOSSODYNIA 6 0.0003
919 SNEEZING 6 0.0003
920 IRRITABILITY 16 0.0003
921 SKIN BURNING SENSATION 19 0.0003
922 COLITIS 10 0.0003
923 NIGHTMARE 9 0.0003
924 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
925 PNEUMONITIS 7 0.0003
926 INSOMNIA 68 0.0003
927 RESPIRATORY ARREST 7 0.0003
928 VAGINAL HAEMORRHAGE 11 0.0003
929 BLOOD PRESSURE FLUCTUATION 6 0.0002
930 MENTAL IMPAIRMENT 6 0.0002
931 COLITIS ULCERATIVE 11 0.0002
932 GASTROINTESTINAL DISORDER 22 0.0002
933 BODY TEMPERATURE INCREASED 5 0.0002
934 HYPERSOMNIA 7 0.0002
935 OSTEOPOROSIS 10 0.0002
936 DEATH 209 0.0002
937 LIVER FUNCTION TEST ABNORMAL 7 0.0002
938 VIRAL INFECTION 8 0.0002
939 EYE PRURITUS 8 0.0002
940 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
941 INTENTIONAL OVERDOSE 15 0.0002
942 LACRIMATION INCREASED 7 0.0002
943 EYE IRRITATION 13 0.0002
944 DRUG EFFECT DECREASED 12 0.0002
945 THERAPY NON-RESPONDER 10 0.0002
946 PSORIASIS 29 0.0002
947 THROAT TIGHTNESS 6 0.0002
948 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
949 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
950 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
951 ANGER 7 0.0002
952 NEEDLE ISSUE 6 0.0002
953 ANXIETY 58 0.0002
954 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
955 DEVICE BREAKAGE 8 0.0002
956 THERAPY CESSATION 10 0.0002
957 INFLUENZA LIKE ILLNESS 16 0.0002
958 BREAST CANCER 18 0.0002
959 PANIC ATTACK 7 0.0002
960 DRUG-INDUCED LIVER INJURY 6 0.0002
961 OCULAR HYPERAEMIA 9 0.0002
962 FLUSHING 19 0.0002
963 NEUTROPENIA 25 0.0002
964 EMOTIONAL DISTRESS 22 0.0002
965 STOMATITIS 11 0.0002
966 LIP SWELLING 6 0.0002
967 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
968 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
969 PROSTATE CANCER 13 0.0002
970 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
971 DRUG ABUSE 13 0.0002
972 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
973 ALOPECIA 30 0.0002
974 PSORIATIC ARTHROPATHY 6 0.0001
975 MIGRAINE 14 0.0001
976 ACNE 11 0.0001
977 DRUG DEPENDENCE 23 0.0001
978 THERAPY INTERRUPTED 10 0.0001
979 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
980 INFUSION RELATED REACTION 9 0.0001
981 TREATMENT FAILURE 11 0.0001
982 SKIN IRRITATION 6 0.0001
983 DISEASE RECURRENCE 6 0.0001
984 DRUG WITHDRAWAL SYNDROME 11 0.0001
985 PRODUCT SUBSTITUTION ISSUE 7 0.0001
986 DRY EYE 6 0.0001
987 DRY SKIN 15 0.0001
988 NO ADVERSE EVENT 20 0.0001
989 DISEASE PROGRESSION 13 0.0001
990 TOXICITY TO VARIOUS AGENTS 14 0.0001
991 COMPLETED SUICIDE 6 0.0001